SUSRF (Surgical Science Sweden AB) EPS without NRI: $0.11 (TTM As of Mar. 2026)


SUSRF Surgical Science Sweden AB SUSRF
82 GF Score
Price $4.00
GF Value $14.19
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB EPS without NRI?

Surgical Science Sweden AB SUSRF -2.20% 82 EPS without NRI is $0.11 as of Mar. 2026. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.19 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks worse than 88.28% on this metric.

Surgical Science Sweden AB's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11.

During the past 12 months, Surgical Science Sweden AB's average earnings per share (NRI) Growth Rate was -62.70% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -29.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 19.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Surgical Science Sweden AB's EPS without NRI or its related term are showing as below:

SUSRF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -29.2   Med: 23.6   Max: 116.9
Current: -29.2

During the past 11 years, Surgical Science Sweden AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 116.90% per year. The lowest was -29.20% per year. And the median was 23.60% per year.

SUSRF's 3-Year EPS without NRI Growth Rate is ranked worse than
88.28% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11 vs SUSRF: -29.20

Surgical Science Sweden AB's EPS (Diluted) for the three months ended in Mar. 2026 was $0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11.

Surgical Science Sweden AB's EPS (Basic) for the three months ended in Mar. 2026 was $0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11.


Surgical Science Sweden AB  (OTCPK:SUSRF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Surgical Science Sweden AB EPS without NRI Related Terms


Surgical Science Sweden AB EPS without NRI Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB EPS without NRI Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.36 0.45 0.24 0.14

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 -0.04 0.04 0.07 0.04

SUSRF vs VEEV, BTSG, TEM: EPS without NRI Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Science Sweden AB PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's PE Ratio without NRI falls into.


SUSRF
82GF Score
Surgical Science Sweden AB SUSRF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.11 mean?
Surgical Science Sweden AB (SUSRF) has a EPS without NRI of $0.11 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Surgical Science Sweden AB and its competitors. According to the industry distribution chart, Surgical Science Sweden AB ranks #452 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 88.3%.
Is Surgical Science Sweden AB's EPS without NRI too high?
Surgical Science Sweden AB's current EPS without NRI is $0.11. The Healthcare Providers & Services industry median EPS without NRI is 11.00. Surgical Science Sweden AB's value of $0.11 is 99% below this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #452 out of 512 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's EPS without NRI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #452 out of 512 companies for EPS without NRI. This places Surgical Science Sweden AB in the lower half of its industry. The industry median EPS without NRI is 11.00. Surgical Science Sweden AB's value of $0.11 is 99% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current EPS without NRI of $0.11 is 99% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current EPS without NRI is $0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.19, compared to a current price of $4.00 — trading 71.8% below its estimated fair value. The current EPS without NRI is $0.11 and 99% below the Healthcare Providers & Services industry median of 11.00. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current EPS without NRI is $0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 71.8% below its estimated GF Value™ of $14.19. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for SUSRF:

  • EPS without NRI: $0.11
  • GF Value™: $14.19 vs. price of $4.00 (71.8% below fair value)
  • GF Score™: 82/100 with 4 warning signs
  • Industry Position: 99% below the Healthcare Providers & Services median (#452 of 512)

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for SUSRF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$14.19
GF Value